CPAP as adjunctive treatment option for chronic heart failure;CPAP-therapie als additive/adjuvante herzinsuffizienztherapie?

Internist

Volumn 47, Issue 2, 2006, Pages 183-191

  Schannwell, C M ^a,b   Strauer, B E ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

Continuous positive airway pressure; Coronary artery disease; CPAP; Heart failure

Indexed keywords

ALDOSTERONE ANTAGONIST; AMIODARONE; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FUROSEMIDE; PHENPROCOUMON; SPIRONOLACTONE; VALSARTAN;

ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CORONARY ARTERY DISEASE; HEART FAILURE; HUMAN; INCIDENCE; MORBIDITY; MORTALITY; POSITIVE END EXPIRATORY PRESSURE; PREVALENCE; PROGNOSIS;

CARDIAC PACING, ARTIFICIAL; CARDIOTONIC AGENTS; COMBINED MODALITY THERAPY; HEART FAILURE, CONGESTIVE; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; TREATMENT OUTCOME;

EID: 32944466763     PISSN: 00209554     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00108-005-1519-1     Document Type: Article

References (41)

1. American Sleep Disorders Association (1995) Practice parameters for the treatment of snoring and obstructive sleep apnea. Sleep 18: 511-513
2. Bradley TD, Floras JS (2003) Sleep apnea and heart failure. Part I: Obstructive sleep apnea. Circulation 107: 1671-1678
3. Brecher GA, Hubay CA (1955) Pulmonary blood flow and venous return during spontaneous respiration. Circulation Research 3: 210-214
4. Dinkel R, Büchner K, Holtz J (1989) Chronische Herzinsuffizienz. Sozioökonomische Bedeutung in der Bundesrepublik Deutschland. Münch Med Wochenschr 131: 686-689
5. Duchna HW, Guilleminault C, Stooths RA, Orth M et al. (2001) Das obstructive Schlafapnoe-Syndrom: Ein kardiovaskulärer Risikofaktor? Z Kardiol 90: 568-575
6. Duchna H-W, Guilleminault C, Stooths RA et al. (2000) Vascular reactivity in obstructive sleep apnea syndrome. Am J Respir Crit Care Med 161: 187-191
7. Freimark D, Adler Y, Sheffy J et al. (2002) Oscillations in peripheral arterial tone in congestive heart failure patients: a new marker for Cheyne-Stokes breathing. Cardiology 98: 21-24
8. Guyton AC (1963) Circulatory physiology: Cardiac output and its regulation. Saunders, Philadelphia
9. Hader C, Sanner B, Rasche K (2004) Das obstructive Schlafapnoe-Syndrom - Diagnostik. Dtsch Med Wochenschr 129: 566-569
10. Ho KKL, Anderson KM, Kannel WB, Grossman W, Levy D (1993) Survival after the onset of congestive heart failure in Framingham heart study subjects. Circulation 88: 107-115
11. Kaneko Y, Floras JS, Usui K et al. (2003) Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med 348: 1233-1241
12. Leung RS, Bradley TD (2001) Sleep apnea and cardiovascular disease. Am J Respir Crit Care Med 164: 2147-2165
13. Lipkin D (1999) Sleep disordered breating in chronic stable heart failure. Lancet 354: 531-532
14. Lloyd TL (1982) Mechanical cardiopulmonary interdependence. J Appl Physiol 52: 333-339
15. Metha S, Liu P, Fitzgerald F, Allinda Y, Bradley T (2000) Effects of continuous positive airway pressure on cardiac volumes in patients with ischemic and dilated cardiomyopathy. Am J Respir Crit Care Med 161: 128-134
16. Narkiewicz K, Kato M, Phillips BG, Pesek CA, Davidson DE, Somers VK (1999) Nocturnal continuous positive airway pressure decreases daytime sympathetic traffic in obstructive sleep apnea. Circulation 100: 2332-2335
17. Narkiewicz K, van de Borne P, Cooley RL, Dyken ME, Somers VK (1998) Sympathetic activity in obese subjects with and without obstructive sleep apnea. Circulation 98: 772-776
18. Naughton MT, Benard D, Liu P, Rutherford R, Rankin F, Bradley D (1995) Effects of nasal CPAP on sympathetic activity in patients with heart failure and central sleep apnea. Am J Respir Crit Care Med 152: 473-479
19. Nieto FJ, Herrington DM, Redline S, Benjamin EJ, Robbins JA (2004) Sleep apnea and markers of vascular endothelial dysfunction in a large community sample of older adults. Am J Respir Care Med 169: 354-360
20. Peppard PE, Young T, Palta M, Skatrud J (2000) Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 342: 1378-1384
21. Permutt S, Wise RA, Brower RG (1989) How changes in pleural and alveolar pressure cause changes in afterload and preload. In: Scharf SM, Cassidy SS (eds) Heart-lung interactions in health and disease. Marcel Dekker, New York Basel, pp 243-250
22. Rich MW, Nease RF (1999) Cost-effectiveness analysis in clinical practice. The case of heart failure. Arch Intern Med 159: 1690-1700
23. Robotham JL, Peters J (1989) Mechanical effects of intrathoracic pressure on ventricular performance. In: Scharf SM, Cassidy SS (eds) Heart-lung interactions in health and disease. Marcel Dekker, New York Basel, pp 251-284
24. Sanner B, Hader C, Rasche K (2004) Das obstruktive Schlafapnoe-Syndrom - Therapie. Dtsch Med Wochenschr 129: 570-572
25. Scharf SM, LM Graver, K Balaban (1992) Cardiovascular effects of periodic occlusion of the upper airways in dogs. Am Rev Respir Dis 146: 321-329
26. Schmidt-Nowara W, Lowe A, Wiegand L, Cartwright R, Perez-Guerra F, Menn S (1995) Oral applicances for the treatment of snoring and obstructive sleep apnea: a review. Sleep 18: 501-510
27. Schulz R, Schmidt D, Blum A et al. (2000) Decreased plasma levels of nitric oxide derivates in obstructive sleep apnea: response to CPAP-therapy. Thorax 55: 1046-1051
28. Shamsuzzaman AS, Gersh BJ, Somers VK (2003) Obstructive sleep apnea: implications for cardiac and vascular disease. JAMA 123: 1536-1543
29. Sin D, Fitzgerald F, Parker et al. (2003) Relationship of systolic BP to obstructive sleep apnea in patients with heart failure. Chest 123: 1536-1543
30. Solin P, Bergin P, Richardson M, Kaye D, Walters E, Naughton M (1999) Influence of pulmonary capillary wedge pressure on central apnea in heart failure. Circulation 99: 1574-1579
31. SOLVD Investigators (1992) Effects of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 327: 685-691
32. Somers VK, Dyken ME, Clary MP, Abboud FM (1995) Sympathetic neural mechanisms in obstructive sleep apnoe. J Clin Invest 96: 1897-1904
33. Steiner S, Peters AJ, Schwalen A, Leschke M, Perings C, Strauer BE (1999) Influence of pulmonary hemodynamics on right ventricular ejection fraction in chronic obstructive pulmonary disease. Pneumologie 53: 249-254
34. Steiner S, Schwartzkopff B, Strauer BE, Schultze-Werninghaus G, Duchna HW (2005) Sleep apnea: significance in patients with heart failure. Pathophysiology, diagnosis and treatment. Dtsch Med Wochenschr 130: 468-472
35. Steiner S, Strauer BE (2004) Functional dynamics of the right ventricle and pulmonary circulation in obstructive sleep apnea. Therapeutic consequences. Internist 45: 1101-1107
36. Strauer BE (1979) Ventricular function and coronary hemodynamics in hypertensive heart disease. Am J Cardiol 44: 999-1006
37. Strauer BE (1991) Das Hochdruckherz. Pathophysiologie - Diagnostik - Differenzialtherapie. Springer, Berlin Heidelberg New York, 561-66
38. Sullivan CE, Issa FG, Berthon-Jones M, Eves L (1981) Reversal of obstructive sleep apnoea by continuous positive airway pressure applied through the nares. Lancet 1: 862-865
39. Takata M, Robotham JL (1992) Effects of inspiratory diaphragmatic descent on inferior vena caval venous return. J Appl Physiol 72: 597-607
40. Thalhofer SA, Kiwus U, Dorow P (2000) Influence of orthotopic heart transplantation on breathing pattern disorders in patients with dilated cardiomyopathy. Sleep Breath 4: 121-126
41. Trinder J, Merson R, Rosenberg JI, Fitzgerald F, Kleiman J, Bradley DT (2000) Pathophysiological interactions of ventilation, arousals, and blood pressure oscillations during cheyne-stoke respiration in patients with heart failure. Am J Respir Crit Care Med 162: 808-813